Skip to content

The use of tiagabine and gabapentin in the treatment of social anxiety disorder in 8 patients

Gabapentin and tiagabine for treatment of social anxiety disorder in 8 patients in a random double blind crossover study with outcome measured as changes in the Leibowitz Social Anxiety Scale

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000091202
Enrollment
8
Registered
2009-02-10
Start date
2003-05-20
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Social Anxiety Disorder creates stress and significant disability for patients. Common treatments like selective serotonin reuptake inhibitors and benzodiazepines have undesirable side effects like sexual dysfunction or the potential for drug abuse/ dependence. The objective of the study was to see if alternative medications - tiagabine and gabapentin - already shown to be effective in other anxiety disorders might be effective for social anxiety disorder too. Subjects were selected to have social anxiety disorder by meeting the DSM-IV criteria and having a high score on the Liebowitz Social Anxiety Scale. Subjects were chosen who were generally healthy and had no other psychiatric diagnoses. They received a physical exam and lab work before starting the study. Each individual received each medication at a steady dosage for 4 weeks after being slowly increased for two weeks. The subjects took a Liebowitz Social Anxiety Scale and Clinical Global Impression Scale on each visit as well as reported efficacy of the medication (unknown to the patient or the investigator) and any side effects. Eight patients completed the study. Both medications were well tolerated with sedation and mild dizziness being the most common. All subjects with severe social anxiety responded well to both medications with two subjects reaching remission of symptoms. Gabapentin and tiagabine should be considered as effective alternate treatments for social anxiety disorder.

Interventions

Each subject was titrated to either 1800 mg gabapentin oral tablets daily or 2400 mg tiagabine oral tablets daily by mouth and stayed at that dosage for 4 weeks before being washed out for 2 weeks and receiving whichever medication they had not initially received.

Sponsors

Maria Urbano, M.D.
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

diagnosis of social anxiety disorder by DSM-IV criterial and a Liebowitz Socail Anxiety Scale greater than 30.

Exclusion criteria

Other Axis I psychiatric disorders, major medical illnesses, taking medications that interacted with the study drugs, actively using alcohol or illegal drugs, were pregnant, planning to become pregnant, or breastfeeding

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026